Xeris Biopharma Holdings, Inc. - COM (XERS)

Historical Portfolio Holders from Q3 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
59.2 M
Holdings value Q1 2024
$131 M
Value change Q1 2024
+$1.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
137
Number of buys Q1 2024
81
Number of sells Q1 2024
-45
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.002%
CUSIP
98422E103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 59.2 M $131 M +$1.1 M $2.21 137
2023 Q4 58.7 M $138 M +$2.61 M $2.35 117
2023 Q3 55.3 M $103 M -$2.38 M $1.86 109
2023 Q2 55.9 M $147 M +$17.8 M $2.62 102
2023 Q1 49.5 M $80.6 M -$5.93 M $1.63 89
2022 Q4 53.9 M $71.6 M -$5.39 M $1.33 93
2022 Q3 49 M $76.5 M -$3.68 M $1.56 93
2022 Q2 59.2 M $91.1 M +$12.1 M $1.54 92
2022 Q1 50.4 M $129 M +$23.9 M $2.56 93
2021 Q4 41 M $120 M +$118 M $2.93 85
2021 Q3 704 K $1.73 M +$1.73 M $2.45 1